Ning Kuo
Currently a NIH T32 grant trainee pursuing a Ph.D. in the Department of Biomedical Sciences program at UC San Diego. Research focuses on harnessing immune chemokine networks and characterizing GPCRs and related signaling pathways in dendritic cells and other immune cells to strengthen current solid cancer immunotherapies. Received a B.S. (Cell & Molecular Biology) and M.S. (Molecular & Integrative Physiology) at the University of Michigan, Ann Arbor. Had experience coordinating clinical trials and mentoring students.
Abstracts this author is presenting: